Article
Pancreatic islet differentiation of human embryonic stem cells by microRNA overexpression
30 Jul 2013
Abstract excerpt
Development of stem cell-based therapies for the treatment of type 1 diabetes would provide a renewable supply of human β-cells. Human embryonic stem cells (ESCs) are considered to be one of the stem cell populations with sufficient proliferative capacity to achieve this goal. Currently, differentiation protocols directing ESCs toward a pancreatic fate employ a variety of expensive cytokines and inhibitors. With...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
